(Q42451245)

English

Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas

scientific article published on 20 March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

author name string

Sharlin Johnykutty

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Ping Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Hongwei Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

David G Hicks

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Shuyuan Yeh

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Xi Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

20 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

770-775

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Estrogen receptor-positive proliferating cells in the normal and precancerous breast.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Is triple negative a prognostic factor in breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Human breast cell proliferation and its relationship to steroid receptor expression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Updates on p53: modulation of p53 degradation as a therapeutic approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

21 January 2018

Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.24

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2009.24

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42451245&oldid=2205398316"